#基因预测

The move from tissue-level averages to single-cell-type resolution changes what genetics labs can do with variant interpretation: rare-disease teams can now pinpoint which specific cell type a variant disrupts rather than relying on broad tissue signals. Computational biologists and genomics researchers can start testing it immediately via the free AlphaGenome API for non-commercial work. Compared with prior variant-effect predictors, the conditional architecture and cross-modal imputation reduce the need to run every assay before planning follow-up experiments.

The interesting shift is that the model's value comes from context — the same variant can be scored across many cell types, enabling tissue-aware interpretation of disease-linked variants that single-context tools miss. Computational biologists, genetics labs and variant-interpretation teams can start experimenting immediately through the free Colab tutorials without infrastructure setup. Commercial users are excluded from the current licence, so biotech teams should treat it as a research preview and watch how DeepMind prices commercial access later.

Official accountGoogle DeepMind@GoogleDeepMindSource